THOXF (Bioporto AS) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 08, 2026)


THOXF Bioporto AS THOXF
69 GF Score
Price $0.15
GF Value $0.16
! 3 Warning Signs
View Full Analysis

What is Bioporto AS 5-Year Yield-on-Cost %?

Bioporto AS THOXF 69 5-Year Yield-on-Cost % is 0.00 as of Jul. 08, 2026. GuruFocus rates THOXF with a GF Score™ of 69/100 and a GF Value™ of $0.16. The stock has 3 warning signs investors should review. Among 64 Medical Diagnostics & Research companies, Bioporto AS ranks worse than 1562498.44% on this metric.

Bioporto AS's yield on cost for the quarter that ended in Dec. 2025 was 0.00.


The historical rank and industry rank for Bioporto AS's 5-Year Yield-on-Cost % or its related term are showing as below:



THOXF's 5-Year Yield-on-Cost % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.395
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Bioporto AS  (OTCPK:THOXF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Bioporto AS 5-Year Yield-on-Cost % Related Terms


THOXF vs TMO, DHR, IDXX: 5-Year Yield-on-Cost % Comparison

For the Diagnostics & Research subindustry, Bioporto AS's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioporto AS 5-Year Yield-on-Cost % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bioporto AS's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Bioporto AS's 5-Year Yield-on-Cost % falls into.


THOXF
69GF Score
Bioporto AS THOXF
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioporto AS 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Bioporto AS is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Bioporto AS (THOXF) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 08, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Bioporto AS and its competitors. According to the industry distribution chart, Bioporto AS ranks #999999 out of 64 companies in the Medical Diagnostics & Research industry.
Is Bioporto AS's 5-Year Yield-on-Cost % too high?
Bioporto AS's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Bioporto AS ranks #999999 out of 64 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Bioporto AS has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Bioporto AS's 5-Year Yield-on-Cost % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Bioporto AS ranks #999999 out of 64 companies for 5-Year Yield-on-Cost %. This places Bioporto AS in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Diagnostics & Research company?
The median 5-Year Yield-on-Cost % among Medical Diagnostics & Research companies is 2.40, based on 64 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Bioporto AS and its competitors. For the Medical Diagnostics & Research industry, the median 5-Year Yield-on-Cost % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioporto AS's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioporto AS stock overvalued right now?
Bioporto AS (THOXF) has a current 5-Year Yield-on-Cost % of 0.00. The stock's GF Value™ is $0.16, compared to a current price of $0.15 — trading 6.9% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Bioporto AS's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Bioporto AS (THOXF), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioporto AS (THOXF) Overvalued in 2026?

Based on GuruFocus' analysis, Bioporto AS stock appears to be undervalued. The current stock price of $0.15 is trading 6.9% below its estimated GF Value™ of $0.16.

Key valuation signals for THOXF:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: $0.16 vs. price of $0.15 (6.9% below fair value)
  • GF Score™: 69/100 with 3 warning signs

No single metric tells the full story. See the THOXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bioporto AS Business Description

Other Exchanges BIOPOR:Denmark
Address Tuborg Havnevej 15, Ground Floor, Hellerup, DNK, DK-2900
Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of its revenue from North America. Geographically, its business area is in North America, Denmark, and rest of Europe, and Asia. The products of the company involve: ProNephro AKI, The NGAL Test, Antibodies, ELISA Kits, gRad Lateral Flow, and others.
69GF Score

Get the complete analysis for THOXF

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15
Price
$0.16
GF Value